| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.31 | 6e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 1e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |